Neil Almstead
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Neil Almstead
The proxy statement of Ptc Therapeutics, Inc. reports total compensation of $2,518,769 for Neil Almstead in fiscal 2019, including a base salary of $468,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ptc Therapeutics, Inc. (PTCT)
Proxy statement
Start not stated–2020-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $468,000 | $2,518,769 |
| 2018 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $434,969 | $1,609,441 |
| 2017 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $434,969 | $951,918 |
Recent activity
No call appearances or filed executive changes recorded yet.